Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Depakote formulations in pediatric epilepsy
NCT00646711Phase 2Completed
- Sponsor
- Abbott Laboratories
- Start
- Feb 2003
- Primary completion
- Dec 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of divalproex sodium in epilepsy (2 arms), sponsored by Abbott Laboratories. Primary endpoints: Number of seizures at 2 weeks and Number of Adverse Events at 2 weeks. Started Feb 2003; status: completed.
02
Drugs
divalproex sodium
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT00646711.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00646711.